February Recruitment Update
Graph displaying the screening and randomisation of Octopus trial participants from January 2023 to February 2024.
We have reached 187 participants screened and 135 randomised!
This means we have screened enough participants to cover one arm of the trial (>125).
Sites are making good progress as Queen's Medical Centre (Nottingham) who opened December 2023 have already screened 2 participants.
Octopus is on track to successfully randomise 375 participants for the Analysis Stage 1.
Check out the table below to see how each site is doing as of 14-Feb-24:
| Site | Number Screened | Number Randomised |
| UCLH (London) | 84 | 71 |
| University Hospital Southampton (Southampton) | 20 | 13 |
| The Anne Rowling Regenerative Neurology clinic (Edinburgh) | 22 | 11 |
| Royal Hallamshire Hospital (Sheffield) | 13 | 10 |
| Belfast City Hospital (Belfast) | 17 | 10 |
| Leeds General Infirmary (Leeds) | 9 | 7 |
| University of Wales (Cardiff) | 6 | 4 |
| Poole Hospital (Poole) | 5 | 3 |
| University Hospital Coventry and Warwickshire (Coventry) | 4 | 4 |
| Addenbrooke's Hospital (Cambridge) | 2 | 1 |
| Queen's Medical Centre (Nottingham) | 2 | 1 |
| Royal Victoria Infirmary (Newcastle) | 3 | 0 |
| Total | 187 | 135 |
